Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Harvard

Rasmussen, B, Göhring, G, Bernard, E, Nilsson, L, Tobiasson, M, Jädersten, M, Garelius, H, Dybedal, I, Grønbaek, K, Ejerblad, E, Lorenz, F, Flogegård, M, Marcher, CW, Öster Fernström, A, Cavelier, L, Papaemmanuil, E, Ebeling, F, Kittang, AO, Nørgaard, JM, Saft, L, Möllgård, L & Hellström-Lindberg, E 2022, '"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"', Leukemia, bind 36, nr. 5, s. 1436-1439. https://doi.org/10.1038/s41375-022-01537-w

APA

Rasmussen, B., Göhring, G., Bernard, E., Nilsson, L., Tobiasson, M., Jädersten, M., Garelius, H., Dybedal, I., Grønbaek, K., Ejerblad, E., Lorenz, F., Flogegård, M., Marcher, C. W., Öster Fernström, A., Cavelier, L., Papaemmanuil, E., Ebeling, F., Kittang, A. O., Nørgaard, J. M., ... Hellström-Lindberg, E. (2022). "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)". Leukemia, 36(5), 1436-1439. https://doi.org/10.1038/s41375-022-01537-w

CBE

Rasmussen B, Göhring G, Bernard E, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Öster Fernström A, Cavelier L, Papaemmanuil E, Ebeling F, Kittang AO, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E. 2022. "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)". Leukemia. 36(5):1436-1439. https://doi.org/10.1038/s41375-022-01537-w

MLA

Vancouver

Author

Rasmussen, Bengt ; Göhring, Gudrun ; Bernard, Elsa ; Nilsson, Lars ; Tobiasson, Magnus ; Jädersten, Martin ; Garelius, Hege ; Dybedal, Ingunn ; Grønbaek, Kirsten ; Ejerblad, Elisabeth ; Lorenz, Fryderyk ; Flogegård, Max ; Marcher, Claus Werenberg ; Öster Fernström, Annette ; Cavelier, Lucia ; Papaemmanuil, Elli ; Ebeling, Freja ; Kittang, Astrid Olsnes ; Nørgaard, Jan Maxwell ; Saft, Leonie ; Möllgård, Lars ; Hellström-Lindberg, Eva. / "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)". I: Leukemia. 2022 ; Bind 36, Nr. 5. s. 1436-1439.

Bibtex

@article{4a77bca6b71f4f47944b43b4b8e2d270,
title = "{"}Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q){"}",
keywords = "Azacitidine, Chromosome Deletion, Chromosomes, Human, Pair 5/genetics, Humans, Karyotype, Lenalidomide/therapeutic use, Leukemia, Myeloid, Acute/drug therapy, Myelodysplastic Syndromes/drug therapy",
author = "Bengt Rasmussen and Gudrun G{\"o}hring and Elsa Bernard and Lars Nilsson and Magnus Tobiasson and Martin J{\"a}dersten and Hege Garelius and Ingunn Dybedal and Kirsten Gr{\o}nbaek and Elisabeth Ejerblad and Fryderyk Lorenz and Max Flogeg{\aa}rd and Marcher, {Claus Werenberg} and {{\"O}ster Fernstr{\"o}m}, Annette and Lucia Cavelier and Elli Papaemmanuil and Freja Ebeling and Kittang, {Astrid Olsnes} and N{\o}rgaard, {Jan Maxwell} and Leonie Saft and Lars M{\"o}llg{\aa}rd and Eva Hellstr{\"o}m-Lindberg",
year = "2022",
month = may,
doi = "10.1038/s41375-022-01537-w",
language = "English",
volume = "36",
pages = "1436--1439",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

AU - Rasmussen, Bengt

AU - Göhring, Gudrun

AU - Bernard, Elsa

AU - Nilsson, Lars

AU - Tobiasson, Magnus

AU - Jädersten, Martin

AU - Garelius, Hege

AU - Dybedal, Ingunn

AU - Grønbaek, Kirsten

AU - Ejerblad, Elisabeth

AU - Lorenz, Fryderyk

AU - Flogegård, Max

AU - Marcher, Claus Werenberg

AU - Öster Fernström, Annette

AU - Cavelier, Lucia

AU - Papaemmanuil, Elli

AU - Ebeling, Freja

AU - Kittang, Astrid Olsnes

AU - Nørgaard, Jan Maxwell

AU - Saft, Leonie

AU - Möllgård, Lars

AU - Hellström-Lindberg, Eva

PY - 2022/5

Y1 - 2022/5

KW - Azacitidine

KW - Chromosome Deletion

KW - Chromosomes, Human, Pair 5/genetics

KW - Humans

KW - Karyotype

KW - Lenalidomide/therapeutic use

KW - Leukemia, Myeloid, Acute/drug therapy

KW - Myelodysplastic Syndromes/drug therapy

UR - http://www.scopus.com/inward/record.url?scp=85126099436&partnerID=8YFLogxK

U2 - 10.1038/s41375-022-01537-w

DO - 10.1038/s41375-022-01537-w

M3 - Letter

C2 - 35277655

VL - 36

SP - 1436

EP - 1439

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -

ID: 77931366